Concepedia

Vânia Hungria

VH

6

Publications

333

Citations

6

H-Index

2011

Active since

Affiliations

São Germano Oncologia(Current)

Vrije Universiteit Amsterdam

Tel Aviv Sourasky Medical Center

Tel Aviv University

University Hospital Brno

Vânia Hungria is an author at São Germano Oncologia specializing in rheumatoid arthritis, health sciences, and bone metabolism.

Top concepts

Publications per year

2011–2025

6

Publications

6

Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma

Vânia Hungria, Paweł Robak, Marek Hus et al. · New England Journal of Medicine · 2024 · 127 citations

Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial

Saad Z. Usmani, Thierry Façon, Vânia Hungria et al. · Nature Medicine · 2025 · 74 citations · Full text

Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid

Saroj Vadhan‐Raj, Roger von Moos, Lesley Fallowfield et al. · Annals of Oncology · 2012 · 63 citations · Full text

, , +10

Vantage 088: Vorinostat in Combination with Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma: Results of a Global, Randomized Phase 3 Trial

Meletios Α. Dimopoulos, Sundar Jagannath, Sung‐Soo Yoon et al. · Blood · 2011 · 40 citations

Phase 3 Study of Teclistamab (Tec) in Combination with Lenalidomide (Len) and Tec Alone Versus Len Alone in Newly Diagnosed Multiple Myeloma (NDMM) As Maintenance Therapy Following Autologous Stem Cell Transplantation (ASCT): Safety Run-in (SRI) Results from the Majestec-4/EMN30 Trial

Elena Zamagni, Tobias Silzle, Ivan Špıčka et al. · Blood · 2024 · 18 citations · Full text

Rows per page

1–5 of 6